BENLYSTA Trademark

Trademark Overview

On Wednesday, February 18, 2015, a trademark application was filed for BENLYSTA with the United States Patent and Trademark Office. The USPTO has given the BENLYSTA trademark a serial number of 86538266. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 7, 2019. This trademark is owned by GlaxoSmithKline Intellectual Property Limited. The BENLYSTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, blood disorders, bone diseases and injuries, cardiovascular diseases, central nervous system disorders, connective tissue disorders, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, nutritional disorders, oncological conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, respiratory diseases, dermatologic disorders, thrombotic diseases, vascular diseases, tendon and muscular damage, back and joint dysfunction, skin wounds, soft tissue damage and disorders, and inflammation; pharmaceutical preparations for conditioning treatment prior to bone marrow and stem cell transplantation
benlysta

General Information

Serial Number86538266
Word MarkBENLYSTA
Filing DateWednesday, February 18, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 7, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, blood disorders, bone diseases and injuries, cardiovascular diseases, central nervous system disorders, connective tissue disorders, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic disease, infectious diseases, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders, nutritional disorders, oncological conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, respiratory diseases, dermatologic disorders, thrombotic diseases, vascular diseases, tendon and muscular damage, back and joint dysfunction, skin wounds, soft tissue damage and disorders, and inflammation; pharmaceutical preparations for conditioning treatment prior to bone marrow and stem cell transplantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 4, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Intellectual Property Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxoSmithKline Intellectual Property Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, October 7, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 7, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2019EXTENSION 5 GRANTED
Wednesday, February 27, 2019EXTENSION 5 FILED
Monday, March 4, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 27, 2019TEAS EXTENSION RECEIVED
Saturday, July 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 26, 2018EXTENSION 4 GRANTED
Thursday, July 26, 2018EXTENSION 4 FILED
Thursday, July 26, 2018TEAS EXTENSION RECEIVED
Thursday, February 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2018EXTENSION 3 GRANTED
Tuesday, February 13, 2018EXTENSION 3 FILED
Tuesday, February 13, 2018TEAS EXTENSION RECEIVED
Saturday, September 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 31, 2017EXTENSION 2 GRANTED
Thursday, August 31, 2017EXTENSION 2 FILED
Thursday, August 31, 2017TEAS EXTENSION RECEIVED
Tuesday, March 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 3, 2017EXTENSION 1 GRANTED
Friday, March 3, 2017EXTENSION 1 FILED
Friday, March 3, 2017TEAS EXTENSION RECEIVED
Tuesday, September 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 6, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 31, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 9, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 9, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, November 21, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, November 21, 2015FINAL REFUSAL E-MAILED
Saturday, November 21, 2015FINAL REFUSAL WRITTEN
Friday, October 30, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, October 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 7, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, October 6, 2015ASSIGNED TO LIE
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 11, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 11, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, March 11, 2015SUSPENSION LETTER WRITTEN
Tuesday, March 10, 2015ASSIGNED TO EXAMINER
Wednesday, March 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 21, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

benlysta diseases disorders conditions damage pharmaceutical tissue joint bone treatment preparations